ISRCTN ISRCTN12135226
DOI https://doi.org/10.1186/ISRCTN12135226
ClinicalTrials.gov (NCT) Nil known
Clinical Trials Information System (CTIS) Nil known
Integrated Research Application System (IRAS) 295136
Protocol serial number IRAS 295136
Sponsor Shrewsbury and Telford Hospital NHS Trust
Funder Investigator initiated and funded
Submission date
14/10/2021
Registration date
03/11/2021
Last edited
22/10/2021
Recruitment status
Not yet recruiting
Overall study status
Ongoing
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims:
An Achilles tendon rupture is a tear of the tendon that connects the calf muscles to the heel bone. Following an Achilles tendon rupture it is routine to protect patients in a cast or a brace to allow them to move around or mobilise. Mobilising is good, encourages the tendon to heal and avoids complications like blood clots in the calf veins. A previous method used a front shell with patients putting weight on the balls of their feet and not loading on the heel area of the foot at all for 6 weeks. Patients managed using this method did well, reporting good outcome scores and functional tasks on assessment. Their tendons did however lengthen slightly and if they had a fall or a stumble, and put too much weight onto the injured leg to stop their fall, could re-rupture their tendons.
Most treatments use a protective brace for at least 8 weeks and many provide support underneath the midfoot and heel such as a boot with wedges. The aim of this study is to compare the outcome of patients following minimally-invasive Achilles tendon repair mobilising for 6 weeks of weight-bearing in an anterior shell with those mobilising for 8 weeks in an anterior shell and heel wedges.

Who can participate?
Patients aged 18-65 years with an acute Achilles tendon rupture who underwent surgery

What does the study involve?
The aim is to study a group of patients who had received a similar repair of their Achilles tendon in terms of suture material and repair technique, but received a longer period of protection for 8 weeks. From 2-8 weeks following repair patients are allowed to mobilise, with the assistance of crutches, in a walker boot with wedges under the midfoot and heel in addition to the anterior cast shell.
Participating in the study involves nothing other than reading the patient information leaflet, agreeing to take part in the study and signing the consent form. The patient’s management and evaluation would actually be routine patient management with nothing additional.

What are the possible benefits and risks of participating?
The only benefit in taking part is the knowledge that patients may be contributing to science. There is a theoretical risk of taking part in that tendons might heal tighter but this does not appear to be the case from previous studies, with tendon lengthening being the main problem.

Where is the study run from?
Shrewsbury & Telford Hospital NHS Trust (UK)

When is the study starting and how long is it expected to run for?
May 2021 to May 2028

Who is funding the study?
Investigator initiated and funded

Who is the main contact?
Mr Mike Carmont
m.carmont@nhs.net

Contact information

Mr Mike Carmont
Scientific

Princess Royal Hospital
Telford
TF1 6TF
United Kingdom

Phone +44 (0)1952 641222 ext 4381
Email m.carmont@nhs.net
Mrs Kelly Hard
Public

Royal Shrewsbury Hospital
Shrewsbury
SY3 8XQ
United Kingdom

Phone +44 (0)1743 261000 ext 1646
Email kellyhard@nhs.net

Study information

Primary study designObservational
Study designNon-randomized cohort comparison study
Secondary study designCohort study
Participant information sheet 40547 _PIS_27Apr21_V3.doc
Scientific titleComparison of methods and duration of post-operative bracing following repair of acute Achilles tendon rupture
Study acronymPOBRAT
Study objectivesThe aim of this study is to compare the outcome of patients following minimally-invasive Achilles tendon repair mobilising for 6 weeks of weight-bearing in an anterior shell with those mobilising for 8 weeks in an anterior shell and heel wedges.
Ethics approval(s)Approved 06/04/2021, South Central - Oxford C Research Ethics Committee (Health Research Authority (Bristol), Ground Floor, Temple Quay House, 2 The Square, BS1 6PN, UK; +44 (0)207 104 8379; oxfordc.rec@hra.nhs.uk), REC ref: 07/MRE08/9
Health condition(s) or problem(s) studiedPost-operative bracing following repair of the Achilles tendon
InterventionContemporaneous data collection is performed at routine follow up at the completion of brace use at 6 and 8 weeks, and at 3, 6, 9 and 12 months following repair. The primary outcome measure is the Heel-Rise Height Index (HRHI), comparing maximal sustained heel-rise of the injured side to the non-injured side at 12 months following repair. The HRHI is an indirect measure of tendon elongation. Secondary outcome measures include the ATRA, a validated direct measure of tendon length, the Achilles tendon Total Rupture Score (ATRS), a patient-reported outcome measure, the Tegner Score, and the Patient Perception of Performance.
Intervention typeProcedure/Surgery
Primary outcome measure(s)

Tendon elongation measured using the Heel-Rise Height Index (HRHI), comparing maximal the sustained heel-rise of the injured side to the non-injured side at 12 months following repair

Key secondary outcome measure(s)

Measured at 3, 6, 9 and 12 months following repair:
1. Tendon length measured using the Achilles Tendon Resting Angle (ATRA)
2. Symptoms and function measured using the Achilles tendon Total Rupture Score (ATRS)
3. Work and sports activities assessed using the Tegner Score

Completion date31/05/2028

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit65 Years
SexAll
Target sample size at registration64
Key inclusion criteria1. Mid-substance Achilles tendon rupture, diagnosed clinically by the presence of a palpable gap to the Achilles tendon, and increased Achilles Tendon Resting Angle and a calf squeeze test
2. Aged 18-65 years
3. Presenting <15 days following rupture
4. Able to understand the spoken and written English language
5. After consultation wishes to have operative repair of the Achilles tendon rather than non-operative management
6. Available for 12 months follow up at Shrewsbury and Telford Hospital NHS Trust
Key exclusion criteria1. Distal Achilles tendon rupture, identified by palpation of the distal stump ending <2 cm proximal to the Achilles insertion
2. Musculotendinous Achilles tendon ruptures, diagnosed by tenderness at the musculotendinous junction and on ultrasonography. Ultrasonography will be used for the confirmation of musculotendinous rupture rather than midsubstance rupture
3. Patients with diabetes mellitus, chronic inflammatory conditions, and musculoskeletal conditions preventing a single heel-rise prior to rupture
4. A previous ipsilateral or contralateral Achilles tendon rupture
5. Patients >110 kg and BMI >30 kg/m² owing to obesity giving an increased risk of wound, cast and functional brace complications
Date of first enrolment31/05/2027
Date of final enrolment01/01/2028

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

The Royal Shrewsbury Hospital
Shrewsbury & Telford Hospital NHS Trust
Mytton Oak Road
Shrewsbury
SY3 8XQ
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
IPD sharing planThe datasets generated during and/or analysed during the current study are/will be available upon request from Mr Mike Carmont (m.carmont@nhs.net). Data will be anonymised before sharing.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet version 3 27/04/2021 21/10/2021 No Yes
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes
Protocol file version 4 28/03/2021 21/10/2021 No No

Additional files

40547 _PROTOCOL_28Mar21_V4.pdf
Protocol file
40547 _PIS_27Apr21_V3.doc
Participant information sheet

Editorial Notes

21/10/2021: Trial's existence confirmed by South Central - Oxford C Research Ethics Committee.